Browse by author
Lookup NU author(s): Dr Jérémie Nsengimana
This is the authors' accepted manuscript of an article that has been published in its final definitive form by American Association for Cancer Research Inc., 2019.
For re-use rights please refer to the publisher's terms and conditions.
© 2019 American Association for Cancer Research.The immune response to melanomaimproves the survival in untreated patients and predicts the response to immune checkpoint blockade. Here, we report genetic and environmental predictors of the immune response in a large primary cutaneous melanoma cohort. Bioinformatic analysis of 703 tumor transcriptomes was used to infer immune cell infiltration and to categorize tumors into immune subgroups, which were then investigated for association with biological pathways, clinicopathologic factors, and copy number alterations. Three subgroups, with "low", "intermediate", and "high" immune signals, were identified in primary tumors and replicated in metastatic tumors. Genes in the low subgroup were enriched for cell-cycle and metabolic pathways, whereas genes in the high subgroup were enriched for IFN and NF-kB signaling. We identified high MYC expression partially driven by amplification, HLA-B downregulation, and deletion of IFNγ and NF-kB pathway genes as the regulators of immune suppression. Furthermore, we showed that cigarette smoking, a globally detrimental environmental factor, modulates immunity, reducing the survival primarily in patients with a strong immune response. Together, these analyses identify a set of factors that can be easily assessed thatmay serve as predictors of response to immunotherapy in patients with melanoma. Significance: These findings identify novel genetic and environmental modulators of the immune response against primary cutaneousmelanoma and predict their impact on patient survival.
Author(s): Pozniak J, Nsengimana J, Laye JP, O'Shea SJ, Diaz JMS, Droop AlastairP, Filia A, Harland M, Davies JR, Mell T, Randerson-Moor JA, Muralidhar S, Hogan SA, Freiberger SN, Levesque MP, Cook GP, Bishop DT, Newton-Bishop J
Publication type: Article
Publication status: Published
Journal: Cancer Research
Online publication date: 01/05/2019
Acceptance date: 25/01/2019
Date deposited: 25/06/2020
ISSN (print): 0008-5472
ISSN (electronic): 1538-7445
Publisher: American Association for Cancer Research Inc.
PubMed id: 30773503
Altmetrics provided by Altmetric